Valuation, from the filing
| Public float | $736.60M | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float per share | $48.71 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 18.6× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 0.9× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 1.5× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
Valuation over time
18.6× earnings today, against a median of 21.6× across 10 years on record. Below its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2025-06-30 | $736.60M | 18.6× | |
| 2024-06-30 | $795.40M | 25.3× | |
| 2023-06-30 | $1.10B | 39.0× | |
| 2022-06-30 | $774.00M | 24.1× | |
| 2021-06-30 | $838.00M | 20.5× | |
| 2020-06-30 | $565.30M | 16.1× | |
| 2019-06-30 | $778.60M | 19.4× | |
| 2018-06-30 | $761.90M | 21.8× | |
| 2017-06-30 | $475.40M | 21.4× | |
| 2016-06-30 | $547.92M | 26.7× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
How this compares in its industry
Percentile among the Services-Health Services filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| Gross margin | 19.2% | 0th | |
| Operating margin | 11.1% | 92th | |
| Net margin | 5.1% | 85th | |
| Long-term debt / equity | 0.32x | 80th | |
| Current ratio | 1.01x | 23th | |
| Effective tax rate | 25.5% | 25th | |
| SBC / revenue | 1.1% | 33th | |
| Revenue YoY growth | 16.3% | 50th |
U S PHYSICAL THERAPY INC /NV (USPH) reported revenue of $812.20M and net income of $32.23M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from U S PHYSICAL THERAPY INC /NV’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Health Services.
Income
| Metric | 2026-06-30 |
|---|---|
| Revenue | $812.20M |
| Cost of revenue | Unavailable |
| Gross profit | $151.70M |
| Operating income | $76.52M |
| Net income | $32.23M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $67.45M |
| Income tax expense | $17.58M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | $72.82M |
| General & administrative | Unavailable |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-30 |
|---|---|
| Cash & equivalents | $24.89M |
| Total assets | $1.25B |
| Current assets | $139.68M |
| Total liabilities | $482.22M |
| Current liabilities | $109.91M |
| Total equity incl. NCI | $449.17M |
| Temporary (mezzanine) equity | $317.49M |
| Inventory | Unavailable |
| Accounts receivable | $69.60M |
| Goodwill | $716.54M |
| Long-term debt | $215.46M |
| Accounts payable | Unavailable |
Cash flow
| Metric | 2026-06-30 |
|---|---|
| Operating cash flow | $83.05M |
| Capital expenditures | Unavailable |
| Investing cash flow | -$63.59M |
| Financing cash flow | -$28.66M |
| Net change in cash | -$9.20M |
| Stock-based compensation | $9.86M |
| Common dividends paid | Unavailable |
| Common share repurchases | Unavailable |
| Depreciation & amortization | $21.75M |
Derived
| Metric | 2026-06-30 |
|---|---|
| Free cash flow | Unavailable |
| Gross margin | 18.7% |
| Operating margin | 9.4% |
| FCF margin | Unavailable |
| SBC / revenue | 1.2% |
| Current ratio | 1.27x |
| Revenue YoY growth | 11.3% |
| Net margin | 4.0% |
| R&D / revenue | Unavailable |
| CapEx / revenue | Unavailable |
| Long-term debt / equity | 0.48x |
| Effective tax rate | 26.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open USPH in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.